Menu
/REGISTER
Montecito
Nixon Peabody
Chase
Bank of America
Loading...
You are here:  Home  >  Biotech  >  Current Article

Amgen’s first quarter earnings beat analyst estimates

By   /   Thursday, April 30th, 2020  /   No Comments

    Print       Email
Thousand Oaks-based biotech giant Amgen's revenues rose 11 percent in the first quarter to $6.2 billion but earnings per share dipped 3 percent to $3.07 apiece.  Sales volumes increased, offset by lower overall prices, Amgen said in filings with regulators April 30. Net income fell 8 percent compared to the previous first quarter to $1.83…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

Leave a Reply

Your email address will not be published. Required fields are marked *

You might also like...

SB County clears path for wine tasting rooms to reopen

Read More →